Molecular biomarker testing for non-small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group

• Main Authors: Sunhee Chang (Author), Hyo Sup Shim (Author), Tae Jung Kim (Author), Yoon-La Choi (Author), Wan Seop Kim (Author), Dong Hoon Shin (Author), Lucia Kim (Author), Heae Surng Park (Author), Geon Kook Lee (Author), Chang Hun Lee (Author)
• Format: Book
• Published: Korean Society of Pathologists & the Korean Society for Cytopathology, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Molecular biomarker testing is the standard of care for non-small cell lung cancer (NSCLC) patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean Molecular Pathology Study Group co-published a molecular testing guideline which contained almost all known genetic changes th...